Wednesday, 16 November 2011 14:25
The following media release was issued on Monday 7th November 2011, about research that indicates a new possible route to developing a vaccine for malaria.
Julian Rayner an EVIMalaR Affiliate, Gavin Wright and their collaborators describe a unique and essential protein–protein interaction between P. falciparum and red blood cells (Rh5 and Basigin) and suggest that blocking this might be a means to develop new treatments.
Please see the press release below.
Media Briefing: identification of crucial interaction between Plasmodium falciparum and red blood cells – paper in Nature
Monday 7 November 2011, 10.30-11.30
Wellcome Trust, 215 Euston Road, London NW1 2BE
11.30 End, opportunity for one-to-one
Press Release from Wellcome Trust Sanger Institute
Paper in prepublication form from Nature
Video available by ftp from email@example.com
Still photography (see Sample Images at end) available from firstname.lastname@example.org
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum.
Cécile Crosnier*, Leyla Y Bustamante*, S Josefin Bartholdson*, Amy K Bei, Michel Theron, Makoto Uchikawa, Souleymane Mboup, Omar Ndir, Dominic P Kwiatkowski, Manoj T Duraisingh, Julian C Rayner, Gavin J Wright
*These authors contributed equally to this work
Nature, published online on Wednesday 8 November 2011